01 / DESIGN
What was studied?
An open-label randomized trial compared a defined chemically synthesized formulation with a reference medicine in Chinese adults with obesity without diabetes.
02 / FINDINGS
What did the researchers report?
The between-group weight-change estimate fell inside the study's predefined equivalence margin. Reported adverse-event frequencies were similar for these two study products.
03 / LIMITS
How should it be interpreted?
Equivalence depends on the tested formulations, margin, population and follow-up. It cannot be extended to an unrelated supplier vial just because the ingredient name is the same.
Voltera Peptide editorial reading note. Based on the linked source record. Methods and corrections.